BlackRock’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

BlackRock’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-677	Closed	-$28K	–	3297
2015 Q2	$28K	Sell	677 -43	-6%	-$1.54K	﹤0.01%	2247
2015 Q1	$25K	Hold	720	–	–	﹤0.01%	2263
2014 Q4	$23K	Hold	720	–	–	﹤0.01%	2314
2014 Q3	$20K	Hold	720	–	–	﹤0.01%	2344
2014 Q2	$21K	Sell	720 -62	-8%	-$1.71K	﹤0.01%	2370
2014 Q1	$22K	Hold	782	–	–	﹤0.01%	2327
2013 Q4	$20K	Hold	782	–	–	﹤0.01%	2379
2013 Q3	$23K	Hold	782	–	–	﹤0.01%	2219
2013 Q2	$22K	Buy	+782	New	+$21.5K	﹤0.01%	2264

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

BlackRock's BRLI Position: Q3 2015 in Review

BlackRock sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 677 shares — an estimated $28K sold.

BlackRock first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $28K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

BlackRock reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
BlackRock sold 677 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $28K.
BlackRock first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
BlackRock's BIO-REFERENCE LABS INC-NEW- position peaked at $28K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on BlackRock's 13F filing for Q3 2015, filed 13 Nov 2015.